Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Yonnyuniksoogobon-dan taken orally promotes hair growth by affecting growth factors in hair roots.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Mesenchymal Stem Cells (MSCs) are promising for multiple therapies, but more research is needed to fully understand and optimize their use.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

*Acorus calamus* has many medicinal benefits but needs more safety research.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Apigenin may help promote hair growth and could treat hair loss.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

A 72-year-old man with sudden taste issues and hair growth was diagnosed with a severe stomach cancer and died within 5 months.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.